EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieÄquivalenzstudie

Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial

A Tabarin iD, S Espiard, T Deutschbein, L Amar iD, D Vezzossi, G Di Dalmazi iD, Y Reznik, J Young iD, R Desailloud, B Goichot, D Drui iD, G Assié iD und 12 weitere

European Journal of Endocrinology · 2026

DOI: 10.1093/ejendo/lvag142 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Endocrinology, 2026. Verfasst von A Tabarin und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology, Metabolism and Nutrition, Hopital Haut Leveque, CHU Bordeaux, 336604 Pessac, France. Hauptthemen laut MEDLINE: Adrenalectomy, Quality of Life, Hydrocortisone, Adrenal Gland Neoplasms. Die Arbeit nennt 32 Literaturangaben. Gefördert von: French Ministry of Health, German Research Foundation, CRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The CHIRACIC trail supported the beneficial effect of adrenalectomy on hypertension in patients with unilateral adrenal incidentalomas associated with mild autonomous cortisol secretion (MACS). Additional assessments evaluated the impact of adrenalectomy on body weight excess, metabolic abnormalities and quality of life.

Design

Multicenter superiority open-label randomized trial comparing adrenalectomy to conservative management.

Methods

Following a run-in phase to control hypertension, receive lifestyle advice and treatment for comorbidities, patients underwent a workup including measurement of body mass index, visceral and total fat, fat mass, fasting blood glucose, HbA1c, oral glucose tolerance test, plasma lipids, and quality of life (QoL). Following randomization, assessment of comorbidities and adaptation of their treatment were performed every 3 months for 13 months. Workup was repeated at the end of the study.

Results

Forty-eight patients were randomly assigned to adrenalectomy (n = 23) and conservative management (n = 25). 93%, 71% and 90% of patients were overweight/obese, prediabetics/diabetics and dyslipidemic, respectively. There was no statistically significant improvement in anthropometric and metabolic parameters after adrenalectomy as compared to conservative management: 21% and 4% of adrenalectomized and conservatively treated obese/overweight patients lost > 5% of body weight, respectively (difference 22%, 95% CI: −2% to 39%). Glycemic status improved in 44% and 33% of adrenalectomized and conservatively treated dysglycemic patients, respectively (difference 10%, 95% CI: −22% to 43%). Dyslipidemia improved in 20% of adrenalectomized and none of conservatively treated dyslipidemic patients. Changes in QoL were not different between groups.

Conclusion

The beneficial effects of adrenalectomy on excess weight, metabolic disorders and QoL demonstrated in the CHIRACIC trial are more limited than those observed for hypertension. Additional randomized interventional studies involving a larger number of patients are needed to support the use of adrenalectomy in the treatment of these comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenalectomyQuality of LifeHydrocortisoneAdrenal Gland NeoplasmsHypertensionHumansFemaleMaleMiddle AgedAgedDyslipidemiasTreatment OutcomeObesityBlood Glucose

Stichwörter der Autor:innen

adrenalectomydiabetesdyslipidemiamild autonomous cortisol secretion (MACS)obesityquality of liferandomized prospective trial

Substanzen

HydrocortisoneBlood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology, Metabolism and Nutrition, Hopital Haut Leveque, CHU Bordeaux, 336604 Pessac, France.
  • Department of Endocrinology, Diabetology, Oncology and Metabolism, CHU Lille, Inserm U1190, EGID, University of Lille, 59045 Lille, France.
  • Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital, University of Würzburg, 97080 Würzburg, Germany.
  • Hôpital Européen Georges Pompidou, Hypertension Unit, Université Paris-Cité, AP-HP, 75015 Paris, France.
  • Adrenal Referral Center, Université Paris Cité, AP-HP, 75015 France.
  • Inserm Paris Cardiovascular Research Center, 75015 Paris, France.

ORCID-Profile: A Tabarin, L Amar, G Di Dalmazi, J Young, D Drui, G Assié, H Lefebvre, K Mai, F Castinetti, E Frison, M C Vantyghem, P Gosse, M Fassnacht

Förderung

  • French Ministry of Health
  • German Research Foundation
  • CRC
  • Transregio

Zitieren

APA

Tabarin, A., Espiard, S., Deutschbein, T., Amar, L., Vezzossi, D., Di Dalmazi, G., Reznik, Y., Young, J., Desailloud, R., Goichot, B., Drui, D., Assié, G., Lefebvre, H., Mai, K., Castinetti, F., Laboureau, S., Terzolo, M., Ferriere, A., Georget, A., …, & CHIRACIC Collaborators (2026). Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvag142

Vancouver

Tabarin A, Espiard S, Deutschbein T, Amar L, Vezzossi D, Di Dalmazi G, et al. Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial. European Journal of Endocrinology. 2026. doi:10.1093/ejendo/lvag142

BibTeX
@article{Tabarin2026,
  author = {Tabarin, A and Espiard, S and Deutschbein, T and Amar, L and Vezzossi, D and Di Dalmazi, G and Reznik, Y and Young, J and Desailloud, R and Goichot, B and Drui, D and Assié, G and Lefebvre, H and Mai, K and Castinetti, F and Laboureau, S and Terzolo, M and Ferriere, A and Georget, A and Frison, E and Vantyghem, M C and Gosse, P and Fassnacht, M and CHIRACIC Collaborators, CHIRACIC Collaborators},
  title = {Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial},
  journal = {European Journal of Endocrinology},
  year = {2026},
  doi = {10.1093/ejendo/lvag142}
}
Kostenlos starten →